Impact of Bilateral Deep Parasternal Intercostal Plane Block on Intraoperative Opioid Consumption in Open Heart Surgery

Sponsor
Indonesia University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05103787
Collaborator
(none)
30
2
2
9
15
1.7

Study Details

Study Description

Brief Summary

This study aims to assess the impact of bilateral deep parasternal intercostal plane block on intraoperative opioid consumption in open heart surgery

Condition or Disease Intervention/Treatment Phase
  • Procedure: deep parasternal intercostal plane block
  • Procedure: control
N/A

Detailed Description

High-dose opioid is associated with various side effects such as nausea, vomiting, urinary retention, and respiratory depression. The neuraxial block (intrathecal, epidural) and peripheral nerve block are regional anesthesia techniques which have the potential to reduce intraoperative opioid consumption. The deep parasternal intercostal plane block is fascial plane block which intended to block anterior cutaneous branch of intercostal nerves.

This study is a double-blind randomized controlled trial. Thirty subjects will be recruited with consecutive sampling method. Eligible subjects with signed informed consent will be randomized into two groups. The first group is the treatment group who will receive bilateral deep parasternal intercostal plane block after induction of anesthesia and the second group will be the control group who will not receive any regional anesthesia. After surgery, extubation time, adverse event (nausea, vomiting), and intensive care unit length of stay will be recorded for both groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Impact of Bilateral Deep Parasternal Intercostal Plane Block on Intraoperative Opioid Consumption in Open Heart Surgery: a Prospective, Double-blind Randomized Controlled Study
Actual Study Start Date :
Oct 4, 2021
Anticipated Primary Completion Date :
Apr 4, 2022
Anticipated Study Completion Date :
Jul 4, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: deep parasternal plane block

Subjects will receive bilateral deep parasternal intercostal plane block after induction of anesthesia.

Procedure: deep parasternal intercostal plane block
Twenty milliliters of 0.25% bupivacaine will be placed bilaterally in the fascial plane between internal intercostal muscle and transversus thoracis muscle at intercostal space 4 or 5, lateral from sternum, with ultrasound guidance using high-frequency linear transducer.

Procedure: control
Skin puncture with needle will be performed on the same location as the treatment group without administration of local anesthetics.

Placebo Comparator: control

subjects will receive skin puncture with needle on the same location as the treatment group without administration of local anesthetics after induction of anesthesia,

Procedure: deep parasternal intercostal plane block
Twenty milliliters of 0.25% bupivacaine will be placed bilaterally in the fascial plane between internal intercostal muscle and transversus thoracis muscle at intercostal space 4 or 5, lateral from sternum, with ultrasound guidance using high-frequency linear transducer.

Procedure: control
Skin puncture with needle will be performed on the same location as the treatment group without administration of local anesthetics.

Outcome Measures

Primary Outcome Measures

  1. Total intraoperative fentanyl dose [intraoperatively]

    Total intraoperative fentanyl dose will be calculated after surgery

Secondary Outcome Measures

  1. Time to first intraoperative fentanyl [intraoperatively]

    Investigators will record time to first fentanyl dose after incision

  2. extubation time [Up to 72 hours after surgery]

    Investigators will record time to extubation after surgery

  3. opioid side effects [within 24 hours after surgery]

    Incidence of nausea and vomiting

  4. Intensive care unit length of stay [Up to 7 days after surgery]

    Investigators will record total time from intensive care unit admission until patient transferred to surgical wars

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 18-70 years old

  • Elective open-heart surgery with median sternotomy approach

Exclusion Criteria:
  • Patient who refuses to participate

  • Patient with local infection in the block area

  • Patient with chronic pain

  • Patient with history of chronic analgesics use

  • Patient who is contraindicated for local anesthetics

  • Patient with cognitive disorder

  • Patient with severe psychiatric disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cipto Mangunkusumo Cental National Hospital Jakarta DKI Jakarta Indonesia 10430
2 Universitas Indonesia Central Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

  • Principal Investigator: Aida Rosita R Tantri, Indonesia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aida Rosita Tantri, Doctor, Indonesia University
ClinicalTrials.gov Identifier:
NCT05103787
Other Study ID Numbers:
  • IndonesiaUAnes119
First Posted:
Nov 2, 2021
Last Update Posted:
Nov 2, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aida Rosita Tantri, Doctor, Indonesia University

Study Results

No Results Posted as of Nov 2, 2021